Cleared Special

K201607 - Eclipse Treatment Planning System v16.1

K201607 is the FDA 510(k) clearance for Eclipse Treatment Planning System v16.1 by Varian Medical Systems, Inc.. It is a Class 2 Radiology device (product code MUJ) cleared through the Special 510(k) pathway after a 25-day FDA review.

K201607 · Varian Medical Systems, Inc. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2020
Decision
25d
Days
Class 2
Risk

K201607 is an FDA 510(k) clearance for the Eclipse Treatment Planning System v16.1. Classified as System, Planning, Radiation Therapy Treatment (product code MUJ), Class II - Special Controls.

Submitted by Varian Medical Systems, Inc. (Palo Alto, US). The FDA issued a Cleared decision on July 10, 2020 after a review of 25 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.5050 - the FDA radiology and imaging software oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Varian Medical Systems, Inc. devices

Submission Details

510(k) Number K201607 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 15, 2020
Decision Date July 10, 2020
Days to Decision 25 days
Submission Type Special
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
82d faster than avg
Panel avg: 107d · This submission: 25d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code MUJ System, Planning, Radiation Therapy Treatment
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.5050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - MUJ System, Planning, Radiation Therapy Treatment

All 130
Devices cleared under the same product code (MUJ) and FDA review panel - the closest regulatory comparables to K201607.
RayStation
K200569 · RaySearch Laboratories AB (PUBL) · Sep 2020
CORVUS
K201350 · Best Nomos · Sep 2020
Syngo.via RT Image Suite
K201444 · Siemens Medical Solutions USA, Inc. · Aug 2020
RayCare 3.1
K200487 · RaySearch Laboratories AB (PUBL) · Jun 2020
Panther Stereotactic
K193459 · Prowess, Inc. · Apr 2020
ClearCalc
K193640 · Radformation, Inc. · Apr 2020